Description |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
pyruvate kinase M1/2 |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Pyruvic acid
- L-Phospholactate
- 2-Phosphoglycolic Acid
- 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one
- 1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine
- 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine
- Copper
- Artenimol
|
Diseases |
|
|
GWAS |
- Apolipoprotein A1 levels ( 32203549)
- Atrial fibrillation ( 30061737)
- Chronic obstructive pulmonary disease or resting heart rate (pleiotropy) ( 30940143)
- Disease progression in age-related macular degeneration (adjusted for baseline) ( 29346644)
- Glucagon levels in response to oral glucose tolerance test (120 minutes) ( 29093273)
- Iris characteristics ( 21835309)
- Reticulocyte fraction of red cells ( 27863252)
|
|
Interacting Genes |
12 interacting genes:
BAK1
EP300
LAPTM5
PKM
RAF1
RNF11
SOX9
UBC
UBE2D2
UBE2D3
UBE2L3
UBE2S
|
55 interacting genes:
ANXA7
APP
ARAF
AURKB
CCR4
CDC25A
CDK4
CDKN1A
CTNNB1
DLC1
DUX4
EGLN3
ENO3
EPM2A
EXOSC5
FGFR1
GRB7
HERC1
HIF1A
HULC
KPNA1
LINC01554
LMO7
LNX1
MAPK1
MDM2
MYL2
MYOC
NAGK
NDRG1
NXT2
OLFM2
PAX8
PIN1
POLE2
PRKN
PTEN
RAF1
RAP1B
RCC1
RELA
RPP14
SHBG
SMN1
SORBS2
SUMO1
SUMO2
TERF1
TINF2
TK1
TRIM35
TRIM55
TRIM63
UCHL5
YWHAQ
|
Entrez ID |
8925 |
5315 |
HPRD ID |
06894 |
01529 |
Ensembl ID |
ENSG00000103657
|
ENSG00000067225
|
Uniprot IDs |
A0A024R5W0
Q15751
|
A0A024R5Z9
B4DNK4
P14618
V9HWB8
|
PDB IDs |
4O2W
4QT6
|
1T5A
1ZJH
3BJF
3BJT
3G2G
3GQY
3GR4
3H6O
3ME3
3SRD
3SRF
3SRH
3U2Z
4B2D
4FXF
4FXJ
4G1N
4JPG
4QG6
4QG8
4QG9
4QGC
4RPP
4WJ8
4YJ5
5X0I
5X1V
5X1W
6B6U
6GG3
6GG4
6GG5
6GG6
6JFB
6NU1
6NU5
6NUB
6TTF
6TTH
6TTI
6TTQ
6V74
6V75
6V76
6WP3
6WP4
6WP5
6WP6
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|